BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

19 hedge funds and large institutions have $1.18M invested in Bellerophon Therapeutics, Inc. in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$358
2
+$7

Top Sellers

1
-$23.5K
2
-$17K
3
-$14.4K
4
TRCT
Tower Research Capital (TRC)
New York
-$3.24K
5
Morgan Stanley
Morgan Stanley
New York
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$376K
2
$218K
3
$214K
4
$110K
5
$70K
6
$52K
7
$31K
8
$26K
9
$23K
10
$22K
11
$16K
12
$11K
13
$8K
14
$2K
15
$1K
16
$1K
17
$1K